David Moss, PRES, CEO, TRES, CFO, SECR, Director, Ten Percent Owner at Tonix Pharma, holds 1.29M shares in Inmune Bio (Ticker: INMB), holds 3.25M shares in Tonix Pharma (Ticker: TNXP). Most recently, David Moss Bought ― shares of Inmune Bio on Sep 30, 2024 for an estimated value of 52.80K.
What is the percentage of profitable transactions made by David Moss?
The percentage of profitable transactions made by David Moss is 71%.
What is the average return per transaction made by David Moss?
The average return per transaction made by David Moss is 13.50%.
What stocks does David Moss hold?
David Moss holds: TNXP, INMB stocks.
What was David Moss’s latest transaction?
David Moss latest transaction was an Informative Buy of $52.80K.
What was David Moss's most profitable transaction?
David Moss’s most profitable transaction was an Informative Buy of INMB stock on March 20, 2023. The return on the trade was 86.90%.
What is David Moss's role in Tonix Pharma?
David Moss's role in Tonix Pharma is PRES, CEO, TRES, CFO, SECR, Director, Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.